<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Harry</First><Last>Mobley</Last></Person>
    <Organization>University of Michigan</Organization>
    <Address>
      <Line>5641 Medical Sciences II  1150 W. Medical Center Dr.</Line>
      <City>Ann Arbor</City>
      <State>MI</State>
      <Zip-Code>48109</Zip-Code>
      <Country>USA</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Person><First>Erin</First><Middle>C</Middle><Last>Hagan</Last></Person>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Amanda</First><Middle>L</Middle><Last>Lloyd</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>David</First><Middle>A</Middle><Last>Rasko</Last></Person>
  </Contributor>

  <Contributor iid="contrib5">
    <Person><First>Gary</First><Middle>J</Middle><Last>Faerber</Last></Person>
  </Contributor>

  <Contributor iid="contrib6">
    <Person><First>Harry</First><Middle>L</Middle><Last>Mobley</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL11006">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>University of Michigan E_coli_CFT073 5.4K array</Title>
    <Accession database="GEO">GPL11006</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>custom-commercial</Distribution>
    <Organism taxid="199310">Escherichia coli CFT073</Organism>
    <Manufacturer>NimbleGen</Manufacturer>
    <Manufacture-Protocol>
High-density DNA array prepared with Maskless Array Synthesizer (MAS) technology. See manufacturer's website at http://www.nimblegen.com/.
    </Manufacture-Protocol>
    <Description>
NimbleGen design name 2006-07-27_TI199310_60mer.
    </Description>
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="NDF">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/platforms/GPL11006/GPL11006_2006-07-27_TI199310_60mer.ndf.gz
    </Supplementary-Data>
    <Supplementary-Data type="NGD">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/platforms/GPL11006/GPL11006_2006-07-27_TI199310_60mer.ngd.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
        <Description>NimbleGen SEQ_ID</Description>
      </Column>
      <Column position="2">
        <Name>ACCESSION</Name>
        <Description>GenBank accession number of E. coli CFT073 genome sequence</Description>
      </Column>
      <Column position="3">
        <Name>ORF</Name>
        <Description>ORF Name  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=search&amp;term=</Link-Prefix>
        <Link-Suffix>[gene name] AND Escherichia coli CFT073[organism]</Link-Suffix>
      </Column>
      <Column position="4">
        <Name>GENE_ID</Name>
        <Description>Entrez GeneID number for the ORF to which the indicated probe set is directed.</Description>
      </Column>
      <Column position="5">
        <Name>SPOT_ID</Name>
      </Column>
    <External-Data rows="5380">
GPL11006-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM602859">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL051_vitro_rep1</Title>
    <Accession database="GEO">GSM602859</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 051, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
051
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 051 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602859/GSM602859_17765702_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602859/GSM602859_17765702_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602859-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602860">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL051_vitro_rep2</Title>
    <Accession database="GEO">GSM602860</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 051, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
051
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of E. coli patient isolate 051 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602860/GSM602860_17774402_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602860/GSM602860_17774402_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602860-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602861">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL051_vitro_rep3</Title>
    <Accession database="GEO">GSM602861</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 051, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
051
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 051 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602861/GSM602861_17774602_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602861/GSM602861_17774602_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602861-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602862">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL121_vitro_rep1</Title>
    <Accession database="GEO">GSM602862</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 121, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
121
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 121 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602862/GSM602862_17778002_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602862/GSM602862_17778002_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602862-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602863">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL121_vitro_rep2</Title>
    <Accession database="GEO">GSM602863</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 121, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
121
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of  E. coli patient isolate 121 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602863/GSM602863_17778202_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602863/GSM602863_17778202_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602863-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602864">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL121_vitro_rep3</Title>
    <Accession database="GEO">GSM602864</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 121, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
121
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 121 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602864/GSM602864_17778302_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602864/GSM602864_17778302_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602864-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602865">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL151_vitro_rep1</Title>
    <Accession database="GEO">GSM602865</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 151, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
151
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 151 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602865/GSM602865_17778402_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602865/GSM602865_17778402_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602865-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602866">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL151_vitro_rep2</Title>
    <Accession database="GEO">GSM602866</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 151, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
151
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of  E. coli patient isolate 151 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602866/GSM602866_17778502_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602866/GSM602866_17778502_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602866-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602867">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL151_vitro_rep3</Title>
    <Accession database="GEO">GSM602867</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 151, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
151
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 151 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602867/GSM602867_17778802_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602867/GSM602867_17778802_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602867-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602868">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL231_vitro_rep1</Title>
    <Accession database="GEO">GSM602868</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 231, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
231
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 231 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602868/GSM602868_14158401_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602868/GSM602868_14158401_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602868-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602869">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL231_vitro_rep2</Title>
    <Accession database="GEO">GSM602869</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 231, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
231
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of  E. coli patient isolate 231 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602869/GSM602869_17797102_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602869/GSM602869_17797102_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602869-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602870">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL231_vitro_rep3</Title>
    <Accession database="GEO">GSM602870</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 231, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
231
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 231 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602870/GSM602870_17797202_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602870/GSM602870_17797202_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602870-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602871">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL241_vitro_rep1</Title>
    <Accession database="GEO">GSM602871</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 241, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
241
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 241 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602871/GSM602871_17779602_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602871/GSM602871_17779602_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602871-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602872">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL241_vitro_rep2</Title>
    <Accession database="GEO">GSM602872</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 241, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
241
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of  E. coli patient isolate 241 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602872/GSM602872_17788302_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602872/GSM602872_17788302_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602872-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602873">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL241_vitro_rep3</Title>
    <Accession database="GEO">GSM602873</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 241, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
241
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 241 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602873/GSM602873_17794302_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602873/GSM602873_17794302_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602873-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602874">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL291_vitro_rep1</Title>
    <Accession database="GEO">GSM602874</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 291, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
291
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 291 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602874/GSM602874_17794402_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602874/GSM602874_17794402_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602874-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602875">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL291_vitro_rep2</Title>
    <Accession database="GEO">GSM602875</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 291, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
291
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of  E. coli patient isolate 291 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602875/GSM602875_17794502_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602875/GSM602875_17794502_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602875-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602876">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL291_vitro_rep3</Title>
    <Accession database="GEO">GSM602876</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 291, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
291
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 291 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602876/GSM602876_17794602_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602876/GSM602876_17794602_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602876-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602877">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL361_vitro_rep1</Title>
    <Accession database="GEO">GSM602877</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 361, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
361
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 361 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602877/GSM602877_17798702_01_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602877/GSM602877_17798702_01_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602877-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602878">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL361_vitro_rep2</Title>
    <Accession database="GEO">GSM602878</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 361, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
361
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of  E. coli patient isolate 361 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602878/GSM602878_17800902_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602878/GSM602878_17800902_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602878-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602879">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL361_vitro_rep3</Title>
    <Accession database="GEO">GSM602879</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 361, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
361
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 361 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602879/GSM602879_17854502_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602879/GSM602879_17854502_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602879-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602880">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL371_vitro_rep1</Title>
    <Accession database="GEO">GSM602880</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 371, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
371
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three biological replicates of E. coli patient isolate 371 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602880/GSM602880_17888202_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602880/GSM602880_17888202_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602880-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602881">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL371_vitro_rep2</Title>
    <Accession database="GEO">GSM602881</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 371, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
371
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three biological replicates of  E. coli patient isolate 371 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602881/GSM602881_17912502_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602881/GSM602881_17912502_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602881-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602882">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL371_vitro_rep3</Title>
    <Accession database="GEO">GSM602882</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 371, vitro</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
371
      </Characteristics>
      <Characteristics tag="condition">
urine in vitro culture
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three biological replicates of E. coli patient isolate 371 cultured in vitro.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602882/GSM602882_18420002_532_RMA_whole_array_calls.txt.gz
    </Supplementary-Data>
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602882/GSM602882_18420002_532_pair.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602882-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602883">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL051_vivo_rep1</Title>
    <Accession database="GEO">GSM602883</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 051, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
051
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 051 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602883/GSM602883_11430701_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602883/GSM602883_11430701_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602883-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602884">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL051_vivo_rep2</Title>
    <Accession database="GEO">GSM602884</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 051, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
051
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of E. coli patient isolate 051 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602884/GSM602884_4545202_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602884-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602885">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL051_vivo_rep3</Title>
    <Accession database="GEO">GSM602885</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 051, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
051
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 051 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602885/GSM602885_4544502_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602885-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602886">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL121_vivo_rep1</Title>
    <Accession database="GEO">GSM602886</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 121, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
121
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 121 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602886/GSM602886_5140502_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602886/GSM602886_5140502_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602886-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602887">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL121_vivo_rep2</Title>
    <Accession database="GEO">GSM602887</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 121, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
121
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of  E. coli patient isolate 121 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602887/GSM602887_5140602_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602887/GSM602887_5140602_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602887-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602888">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL121_vivo_rep3</Title>
    <Accession database="GEO">GSM602888</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 121, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
121
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 121 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602888/GSM602888_5141802_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602888/GSM602888_5141802_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602888-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602889">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL151_vivo_rep1</Title>
    <Accession database="GEO">GSM602889</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 151, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
151
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 151 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602889/GSM602889_11963101_532_RMA.calls.gz
    </Supplementary-Data>
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602889/GSM602889_5171602_532.pair.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602889-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602890">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL151_vivo_rep2</Title>
    <Accession database="GEO">GSM602890</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 151, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
151
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of  E. coli patient isolate 151 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602890/GSM602890_6343002_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602890/GSM602890_6343002_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602890-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602891">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL151_vivo_rep3</Title>
    <Accession database="GEO">GSM602891</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 151, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
151
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 151 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602891/GSM602891_6343102_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602891/GSM602891_6343102_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602891-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602892">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL231_vivo_rep1</Title>
    <Accession database="GEO">GSM602892</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 231, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
231
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 231 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602892/GSM602892_12124101_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602892/GSM602892_12124101_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602892-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602893">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL231_vivo_rep2</Title>
    <Accession database="GEO">GSM602893</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 231, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
231
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of  E. coli patient isolate 231 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602893/GSM602893_12124301_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602893/GSM602893_12124301_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602893-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602894">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL231_vivo_rep3</Title>
    <Accession database="GEO">GSM602894</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 231, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
231
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 231 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602894/GSM602894_12136301_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602894/GSM602894_12136301_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602894-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602895">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL241_vivo_rep1</Title>
    <Accession database="GEO">GSM602895</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 241, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
241
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 241 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602895/GSM602895_12136601_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602895/GSM602895_12136601_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602895-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602896">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL241_vivo_rep2</Title>
    <Accession database="GEO">GSM602896</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 241, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
241
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of  E. coli patient isolate 241 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602896/GSM602896_12136901_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602896/GSM602896_12136901_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602896-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602897">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL241_vivo_rep3</Title>
    <Accession database="GEO">GSM602897</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 241, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
241
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 241 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602897/GSM602897_12153301_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602897/GSM602897_12153301_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602897-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602898">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL291_vivo_rep1</Title>
    <Accession database="GEO">GSM602898</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 291, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
291
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 291 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602898/GSM602898_11832902_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602898/GSM602898_11832902_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602898-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602899">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL291_vivo_rep2</Title>
    <Accession database="GEO">GSM602899</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 291, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
291
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of  E. coli patient isolate 291 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602899/GSM602899_11833102_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602899/GSM602899_11833102_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602899-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602900">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL291_vivo_rep3</Title>
    <Accession database="GEO">GSM602900</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 291, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
291
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 291 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602900/GSM602900_11835902_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602900/GSM602900_11835902_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602900-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602901">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL361_vivo_rep1</Title>
    <Accession database="GEO">GSM602901</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 361, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
361
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 361 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602901/GSM602901_11836102_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602901/GSM602901_11836102_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602901-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602902">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL361_vivo_rep2</Title>
    <Accession database="GEO">GSM602902</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 361, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
361
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of  E. coli patient isolate 361 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602902/GSM602902_11836202_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602902/GSM602902_11836202_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602902-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602903">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL361_vivo_rep3</Title>
    <Accession database="GEO">GSM602903</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 361, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
361
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 361 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602903/GSM602903_11836302_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602903/GSM602903_11836302_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602903-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602904">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL371_vivo_rep1</Title>
    <Accession database="GEO">GSM602904</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 371, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
371
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
First of three technical replicates of E. coli patient isolate 371 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602904/GSM602904_11836502_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602904/GSM602904_11836502_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602904-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602905">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL371_vivo_rep2</Title>
    <Accession database="GEO">GSM602905</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 371, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
371
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Second of three technical replicates of  E. coli patient isolate 371 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602905/GSM602905_11836602_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602905/GSM602905_11836602_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602905-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM602906">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-16</Release-Date>
      <Last-Update-Date>2010-11-16</Last-Update-Date>
    </Status>
    <Title>E_coli_AL371_vivo_rep3</Title>
    <Accession database="GEO">GSM602906</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>Escherichia coli, 371, vivo</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="isolate">
371
      </Characteristics>
      <Characteristics tag="condition">
patient urine in vivo
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Total RNA was extracted using the RNAprotect reagent (Qiagen Inc., Valencia, CA, USA) and the RNeasy Mini kit (Qiagen) and DNA was removed by TURBO DNase digestion (Ambion Inc., Austin, TX, USA). RNA quality was determined by analysis with an Agilent 2100 bioanalyzer at the University of Michigan Affymetrix and Microarray Core Facility (University of Michigan Medical School, Ann Arbor, MI USA) and RNA concentration determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Rockford, IL, USA).
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
Labeling was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Hybridization was performed by NimbleGen Systems Inc., Madison, WI, USA following their standard operating protocol. See www.nimblegen.com.
    </Hybridization-Protocol>
    <Scan-Protocol>
Scanning was performed by NimbleGen Systems Inc., Madison, WI USA, following their standard operating protocol. See www.nimblegen.com.
    </Scan-Protocol>
    <Description>
Third of three technical replicates of E. coli patient isolate 371 directly from human urine.
    </Description>
    <Data-Processing>
The raw data (.pair file) was subjected to RMA (Robust Multi-Chip Analysis; Irizarry et al. Biostatistics 4(2):249), quantile normalization (Bolstad et al. Bioinformatics 19(2):185), and background correction as implemented in the NimbleScan software package (Roche NimbleGen, Inc.).
    </Data-Processing>
    <Platform-Ref ref="GPL11006" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="PAIR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602906/GSM602906_11840402_532.pair.gz
    </Supplementary-Data>
    <Supplementary-Data type="CALLS">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM602nnn/GSM602906/GSM602906_11840402_532_RMA.calls.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>RMA-normalized, averaged gene-level signal intensity</Description>
      </Column>
    <External-Data rows="5380">
GSM602906-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE24478">
    <Status database="GEO">
      <Submission-Date>2010-10-01</Submission-Date>
      <Release-Date>2010-11-12</Release-Date>
      <Last-Update-Date>2012-03-22</Last-Update-Date>
    </Status>
    <Title>Escherichia coli global gene expression in urine from women with urinary tract infection</Title>
    <Accession database="GEO">GSE24478</Accession>
    <Pubmed-ID>21085611</Pubmed-ID>
    <Summary>
Examination of E. coli transcripts present in bacteria in urine samples from 8 patients attending a urology clinic with symptoms of cystitis, as compared to transcripts present in the same E. coli strains during mid-exponential growth in filter-sterilized human urine in vitro.
    </Summary>
    <Overall-Design>
A 48 array study using total RNA recovered from eight clinical E. coli isolates immediately following collection from women and following culture in pooled human urine ex vivo.  Each array measures the expression of the 5,379 ORFs in the CFT073 genome, using an average of 14 60-mer probes per ORF.  Arrays were performed in triplicate: biological replicates of the in vitro-cultured samples and technical replicates of the in vivo samples.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib2" position="1" />
    <Contributor-Ref ref="contrib3" position="2" />
    <Contributor-Ref ref="contrib4" position="3" />
    <Contributor-Ref ref="contrib5" position="4" />
    <Contributor-Ref ref="contrib6" position="5" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM602859" />
    <Sample-Ref ref="GSM602860" />
    <Sample-Ref ref="GSM602861" />
    <Sample-Ref ref="GSM602862" />
    <Sample-Ref ref="GSM602863" />
    <Sample-Ref ref="GSM602864" />
    <Sample-Ref ref="GSM602865" />
    <Sample-Ref ref="GSM602866" />
    <Sample-Ref ref="GSM602867" />
    <Sample-Ref ref="GSM602868" />
    <Sample-Ref ref="GSM602869" />
    <Sample-Ref ref="GSM602870" />
    <Sample-Ref ref="GSM602871" />
    <Sample-Ref ref="GSM602872" />
    <Sample-Ref ref="GSM602873" />
    <Sample-Ref ref="GSM602874" />
    <Sample-Ref ref="GSM602875" />
    <Sample-Ref ref="GSM602876" />
    <Sample-Ref ref="GSM602877" />
    <Sample-Ref ref="GSM602878" />
    <Sample-Ref ref="GSM602879" />
    <Sample-Ref ref="GSM602880" />
    <Sample-Ref ref="GSM602881" />
    <Sample-Ref ref="GSM602882" />
    <Sample-Ref ref="GSM602883" />
    <Sample-Ref ref="GSM602884" />
    <Sample-Ref ref="GSM602885" />
    <Sample-Ref ref="GSM602886" />
    <Sample-Ref ref="GSM602887" />
    <Sample-Ref ref="GSM602888" />
    <Sample-Ref ref="GSM602889" />
    <Sample-Ref ref="GSM602890" />
    <Sample-Ref ref="GSM602891" />
    <Sample-Ref ref="GSM602892" />
    <Sample-Ref ref="GSM602893" />
    <Sample-Ref ref="GSM602894" />
    <Sample-Ref ref="GSM602895" />
    <Sample-Ref ref="GSM602896" />
    <Sample-Ref ref="GSM602897" />
    <Sample-Ref ref="GSM602898" />
    <Sample-Ref ref="GSM602899" />
    <Sample-Ref ref="GSM602900" />
    <Sample-Ref ref="GSM602901" />
    <Sample-Ref ref="GSM602902" />
    <Sample-Ref ref="GSM602903" />
    <Sample-Ref ref="GSM602904" />
    <Sample-Ref ref="GSM602905" />
    <Sample-Ref ref="GSM602906" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE24478/GSE24478_RAW.tar
    </Supplementary-Data>
    <Relation type="BioProject" target="http://www.ncbi.nlm.nih.gov/bioproject/132507" />
  </Series>

</MINiML>
